Urinary Tract Infections: In the pool of five placebo-controlled clinical trials, the incidence of urinary tract infections (e.g., urinary tract infection, asymptomatic bacteriuria, and cystitis) was increased in patients treated with empagliflozin compared to placebo (see Table 2)
Common misunderstandings to clarify include: Published literature does not equal product-page claims
In Canada, a CSP can only take effect if the underlying patent is still in force
doi:10.1111/head.13540 Luwen H, Ping C, Qing-Rong O, Lei X, Linlin L, Yu M
The most common side effects associated with GLP-1 agonists include appetite loss, nausea, vomiting, and diarrhea, which are often more pronounced when starting the medication or increasing the dosage (4)(10)(23)
however, weight data were unavailable for 55.4% of cases